Scan to Download
The Indian currency appreciated 0.31% to 77.49 during the session.
Rupee trimmed some of the gains to close at 77.55.
Source: Bloomberg
The broader indices underperformed their larger peers, with both the MidCap and SmallCap measures rising nearly 2%. All the 19 sectoral indices compiled by BSE Ltd. advanced, with Realty gauge rising over 4%.
The market breadth was skewed in the favour of bulls. About 2,523 stocks rose, 828 fell and 115 remained unchanged.
After Surprise Loss, Lupin Expects Much-Better Earnings In Second Half Of FY23
The Board approved the transfer of Rs 30,307 crore as surplus to the Central Government for the accounting year 2021-22, while deciding to maintain the Contingency Risk Buffer at 5.50%.RBI Release
HDFC Bank informs the exchanges that the total foreign shareholding in the company as of May 13, 2022 was 66.55% of its total issued and paid-up share capital.
This includes the 20.98% of shareholding held by HDFC Ltd. and its subsidiaries - being promoters)
The company has issued this clarification in response to queries from several investors seeking information on its aggregate foreign shareholding.
Source: Exchange filing
NTPC has successfully commissioned the second part capacity of 35 Mega Watt out of 92 Mega Watt Kayamkulam Floating Solar PV project at Kayamkulam, Kerala.
The capacity is declared on commercial operation with effect from 6 a.m. on Thursday.
The first part capacity of 22 Mega Watt has already been declared on commercial operation on March 31.
The standalone installed and commercial capacity of NTPC now stands at 54,651.68 Mega Watt.
Source: Exchange Filing
HDFC informs the exchanges that the total foreign shareholding in the company as of May 13, 2022 was 68.56% of its total issued and paid-up share capital.
The company has issued this clarification in response to queries from several investors seeking information on its aggregate foreign shareholding.
Source: Exchange filing.
The Sensex gained over 1,200 points (about 2.3%) to 54,003.51. The Nifty advanced by similar magnitude to 16,179.55. About 47 stocks in the 50-stock gauge rose while three declined.
The broader indices underperformed their larger peers, with the S&P BSE MidCap and SmallCap adding 1.5%. All 19 sectoral indices compiled by BSE Ltd. advanced with S&P BSE Realty gaining over 3%.
The market breadth was skewed in the favour of bulls. About 2,457 stocks advanced, 759 declined and 139 remained unchanged.
eMudhra IPO Subscription Status: Day 1 Live Updates
Ethos IPO Subscription Status: Day 3 Live Updates
Prudent Corporate Lists At 4.7% Premium To IPO Price
The Supreme Court has allowed the export of iron ore mined from Karnataka, noting that the situation has changed since the restrictions were imposed in 2013.
The Supreme Court added that export of iron ore is allowed subject to terms and conditions imposed by Government of India.
Dr Reddy's Shares Rise As Analysts Bet On New Launches In US, India To Drive Growth
Rupee Rises 7 Paise To 77.49 Against U.S. Dollar In Early Trade
The broader indices almost mirrored their larger peers. All the 19 sectoral indices compiled by BSE Ltd. advanced with S&P BSE Metal gaining over 3.5%.
The market breadth was skewed in the favour of bulls. About 1,964 stocks advanced, 277 declined and 57 remained unchanged.
Glenmark Pharmaceuticals' U.S. subsidiary received final approval by the U.S. FDA for Abiraterone Acetate tablets USP, 500 mg.
The drug is a generic version of Zytiga tablets, 500 mg, of Janssen Biotech.
The drug is used treat men with prostrate cancer that has spread to other parts of the body.
According to IQVIA annual sales data for the period ending March 2022, Zytiga tablets, 500 mg achieved annual sales of $260.2 million.
Glenmark has 1173 products in its portfolio, authorized for distribution in the U.S. It also has 49 ANDAs pending approval.
Source: Exchange filing
The Indian Rupee could open stronger against the U.S. dollar tody supported by a fall in the greenback and easing bond yields.
Rupee could open around 77.45-77.50 in initial trades compared with 77.73 on Thursday.
Indian bond yields will likely trade in a small trading band as investors await fresh supply of debt at a weekly debt auction today.
Source: Reliance Securities note
Prudent Corporate Advisory Services: Shares to list on the bourses today. The IPO was subscribed 1.22 times. The independent wealth management and a leading mutual fund distributor sold shares at Rs 595-630 apiece and sought to raise Rs 538 crore. The proceeds would go to selling shareholders.
NTPC
Indigo Paints
Thermax
IDFC
Sobha
Pfizer
Nuvoco Vistas Corporation
Metro Brands
C.E. Infosystems
Indiabulls Housing Finance
JK Tyres and Industries
Hindustan Foods
Heidelberg Cement
Amara Raja Batteries
ZF Commercial Vehicle Control Systems
Advanced Enzyme Technologies
Biocon: The company’s subsidiary Biocon Biologics and Viatris Inc launched Abevmy, a biosimilar, in Canada.
DishTV: The company will hold extraordinary general meeting on June 24.
Wipro: The company launched Innovation Studio in Austin, Texas.
Hindustan Aeronautics: The company was granted the Type certification of first Indigenous Light Transport civil passenger aircraft. Hindustan 228-201 aircraft is the first Type certified fixed wing aircraft in India complying with latest FAR 23 certification requirement
Godrej Consumer Products Q4 FY22 (Consolidated, YoY)
Revenue up 7% at Rs 2915.82 crore Vs Rs 2,730.74 (Bloomberg Estimate: Rs 2,905.64)
EBITDA fell 15% at Rs 467.58 crore Vs Rs 549 crore (Bloomberg Estimate: Rs 567.36 crore)
EBITDA margin 16% Vs 20.1% (Bloomberg Estimate: 19.5%)
Net profit fell 1% at Rs 363.24 crore Vs Rs 365.84 crore (Bloomberg Estimate: Rs 398.12 crore)
Gland Pharma Q4 FY22 (Consolidated, YoY)
Revenue up 24% at Rs 1,103 crore Vs Rs 888 crore (Bloomberg estimate: Rs 1,089 crore)
EBITDA up 6% to Rs 348 crore from Rs 328 crore (Bloomberg estimate: Rs 413 crore Profit)
Margins at 31.6% Vs 36.9% (Bloomberg estimate: 37.9%)
Net profit up 10% to Rs 286 crore Vs Rs 260 crore (Bloomberg estimate: Rs 297 crore)
Ashok Leyland Q4 FY22 (Consolidated, YoY)
Revenue up 22% at Rs 9,926.97 crore Vs Rs 8,142.11 crore
EBITDA up 17.8% at Rs 1,194.11 crore Vs Rs 1013.3 crore
EBITDA margin 12.03% Vs 12.45%
Net profit fell 60.22% at Rs 140.24 crore Vs Rs 352.56 crore. Exceptional loss on account of impairment of goodwill and assets was Rs 236.91 crore in Q4 FY22.
Recommended dividend of Rs 1 per share of face value of Rs 1 each.
Appointed Rajesh Sethuraman as Chief Executive Officer of ASEAN and Vijay Kannan as Head of Business Transformation and Digital.
Container Corporation of India Q4 FY22 (Consolidated, YoY)
Revenue up 5.16% at Rs 2,057.56 crore Vs Rs 1,956.69 crore
EBITDA up 112.53% at Rs 415.84 crore Vs Rs 195.66 crore
EBITDA margin 20.21% Vs 10% (Bloomberg Estimate:
Net profit up 900% at Rs 257.56 crore Vs Rs 25.76 crore
Recommended final dividend of Rs 3 per share of face value of Rs 5 each
HPCL Q4 FY22 (Consolidated, YoY)
Revenue up 30.4% at Rs 97,288.11 crore Vs Rs 74,605.76 crore (Bloomberg Estimate: Rs 1,12,700 crore)
EBITDA fell 58.86% at Rs 1,825.53 crore Vs Rs 4,437.81 crore (Bloomberg Estimate: Rs 2,918.4 crore)
EBITDA margin 1.74% Vs 5.22% (Bloomberg Estimate: 2.58%)
Net profit fell 34% at Rs 2,018.45 crore Vs Rs 3,060.7 crore (Bloomberg Estimate: Rs 1,375.8 crore)
Recommended final dividend of Rs 14 per share of face value of Rs 10 each
Krishna Institute of Medical Sciences Q4 FY22 (Consolidated, QoQ)
Revenue fell 5.4% at Rs 372.33 crore Vs Rs 393.56 crore
EBITDA fell 12.5% at Rs 113.56 crore Vs Rs 129.74 crore
EBITDA margin 30.5% Vs 32.97%
Net profit fell 0.6% at Rs 80.68 crore Vs Rs 81.17 crore
Endurance Technologies Q4 FY22 (Consolidated, QoQ)
Revenue up 10.04% at Rs 2,078.79 crore Vs Rs 1,889.12 crore
EBIT up 42.16% at Rs 159.01 crore Vs Rs 111.85 crore
EBIT margin 7.65% Vs 5.92%
Net profit up 44% at Rs 136.18 crore Vs Rs 94.63 crore
Recommended dividend of Rs 6.25 per share of face value of Rs 10 each
Chambal Fertilisers & Chemicals Q4 FY22 (Consolidated, YoY)
Revenue up 101.5% at Rs 3,307.37 crore Vs Rs 1640.76 crore
EBITDA up 26.55% at Rs 361.43 crore Vs Rs 285.6 crore
EBITDA margin 10.93% Vs 17.41%
Net profit fell 45.62% at Rs 243.57 crore Vs Rs 447.89 crore
Recommended final dividend of Rs 3 per share of face value of Rs 10 each
Prince Pipes and Fittings Q4 FY22 (Consolidated, YoY)
Revenue up 18.37% at Rs 901.19 crore Vs Rs 761.35 crore
EBITDA fell 4.29% at Rs 140.50 crore Vs Rs 146.79 crore
EBITDA margin 15.6% Vs 19.28%
Net profit fell 9.25% at Rs 88.23 crore Vs Rs 97.22 crore
Recommended final dividend of Rs 2 per share of face value of Rs 10 each
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
